TME PHARMA - 1H - Technical analysis published on 11/07/2023 (GMT)
- 234
- 0
Click here for a new analysis!
- Timeframe : 1H
- - Analysis generated on
- Status : TARGET REACHED
Analysis too old. There are no more charts available.
Summary of the analysis
Additional analysis
Quotes
TME PHARMA rating 0.4500 EUR. The price registered an increase of +18.58% on the session and was between 0.3500 EUR and 0.4700 EUR. This implies that the price is at +28.57% from its lowest and at -4.26% from its highest.The Central Gaps scanner detects a bearish gap which is a sign that the sellers have taken the lead in the very short term.
Opening Gap DOWN
Type : Bearish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
Abnormal volumes
Timeframe : 5 days
Abnormal volumes
Timeframe : 20 days
Abnormal volumes
Timeframe : 50 days
Technical
Technical analysis of this 1H chart of TME PHARMA indicates that the overall trend is slightly bullish. 60.71% of the signals given by moving averages are bullish. This slightly bullish trend could be reinforced by the strong bullish signals given by short-term moving averages. The Central Indicators scanner detects bullish signals on moving averages that could impact this trend:
Bullish trend reversal : adaptative moving average 50
Type : Bullish
Timeframe : 1 hour
Bullish price crossover with adaptative moving average 50
Type : Bullish
Timeframe : 1 hour
In fact, 14 technical indicators on 18 studied are currently positioned bullish. Caution: the Central Indicators scanner currently detects an excess:
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : 1 hour
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : 1 hour
Pivot points : price is over resistance 3
Type : Neutral
Timeframe : 1 hour
Parabolic SAR indicator bullish reversal
Type : Bullish
Timeframe : 1 hour
Aroon indicator bullish trend
Type : Bullish
Timeframe : 1 hour
SuperTrend indicator bullish reversal
Type : Bullish
Timeframe : 1 hour
An analysis of the price chart with the Central Patterns scanner (detector of chart patterns and resistances and supports) shows a result that can have an impact on the price change:
Resistance of channel is broken
Type : Bullish
Timeframe : 1 hour
The Central Candlesticks scanner which studies Japanese candlesticks did not detect anything.
S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|
ProTrendLines | 0.3766 | 0.4500 | 0.5690 | 0.9940 | 1.1086 |
Change (%) | -16.31% | - | +26.44% | +120.89% | +146.36% |
Change | -0.0734 | - | +0.1190 | +0.5440 | +0.6586 |
Level | Major | - | Intermediate | Minor | Intermediate |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.3522 | 0.3658 | 0.3727 | 0.3863 | 0.3932 | 0.4068 | 0.4137 |
Camarilla | 0.3739 | 0.3757 | 0.3776 | 0.3795 | 0.3814 | 0.3833 | 0.3851 |
Woodie | 0.3488 | 0.3641 | 0.3693 | 0.3846 | 0.3898 | 0.4051 | 0.4103 |
Fibonacci | 0.3658 | 0.3737 | 0.3785 | 0.3863 | 0.3942 | 0.3990 | 0.4068 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.0947 | 0.2323 | 0.3197 | 0.4573 | 0.5447 | 0.6823 | 0.7697 |
Camarilla | 0.3451 | 0.3658 | 0.3864 | 0.4070 | 0.4276 | 0.4483 | 0.4689 |
Woodie | 0.0695 | 0.2198 | 0.2945 | 0.4448 | 0.5195 | 0.6698 | 0.7445 |
Fibonacci | 0.2323 | 0.3183 | 0.3714 | 0.4573 | 0.5433 | 0.5964 | 0.6823 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | -1.2717 | -0.4733 | -0.0467 | 0.7517 | 1.1783 | 1.9767 | 2.4033 |
Camarilla | 0.0431 | 0.1554 | 0.2677 | 0.3800 | 0.4923 | 0.6046 | 0.7169 |
Woodie | -1.4575 | -0.5663 | -0.2325 | 0.6588 | 0.9925 | 1.8838 | 2.2175 |
Fibonacci | -0.4733 | -0.0054 | 0.2837 | 0.7517 | 1.2196 | 1.5087 | 1.9767 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
RSI (14): | 61.95 | |
MACD (12,26,9): | -0.0005 | |
Directional Movement: | 18.9649 | |
AROON (14): | 14.2857 | |
DEMA (21): | 0.3983 | |
Parabolic SAR (0,02-0,02-0,2): | 0.3524 | |
Elder Ray (13): | 0.0507 | |
Super Trend (3,10): | 0.3793 | |
Zig ZAG (10): | 0.4690 | |
VORTEX (21): | 0.9793 | |
Stochastique (14,3,5): | 80.43 | |
TEMA (21): | 0.4104 | |
Williams %R (14): | -0.83 | |
Chande Momentum Oscillator (20): | 0.0740 | |
Repulse (5,40,3): | 6.2930 | |
ROCnROLL: | 1 | |
TRIX (15,9): | -0.2697 | |
Courbe Coppock: | 0.79 |
MA7: | 0.4299 | |
MA20: | 0.4802 | |
MA50: | 1.0212 | |
MA100: | 1.2179 | |
MAexp7: | 0.4100 | |
MAexp20: | 0.4030 | |
MAexp50: | 0.4135 | |
MAexp100: | 0.4553 | |
Price / MA7: | +4.68% | |
Price / MA20: | -6.29% | |
Price / MA50: | -55.93% | |
Price / MA100: | -63.05% | |
Price / MAexp7: | +9.76% | |
Price / MAexp20: | +11.66% | |
Price / MAexp50: | +8.83% | |
Price / MAexp100: | -1.16% |
News
The latest news and videos published on TME PHARMA at the time of the analysis were as follows:
- TME Pharma N.V.: Half-yearly Report on the Liquidity Contract With Invest Securities
- TME Pharma Provides Positive Data Update on Best Response to Therapy With First Complete Response in GLORIA Trial in Glioblastoma, Bringing 50% of Patients in Expansion Arm to Complete or Near-Complete Response
- TME Pharma Announces Positive 15-month Survival Data From GLORIA Expansion Arm Evaluating NOX-A12 in Combination With Radiotherapy and Bevacizumab in Glioblastoma
- TME Pharma Receives Investigational New Drug (IND) Approval for NOX-A12 From the US FDA
- TME Pharma Announces Convocation of the 2023 Annual General Meeting of Shareholders
Add a comment
Comments
0 comments on the analysis TME PHARMA - 1H